STOCK TITAN

[8-K] VSEE HEALTH, INC. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

VSee Health (VSEE) amended its senior secured convertible note. On October 21, 2025, the company executed Amendment No. 1, resetting the Note’s defined “Conversion Price” to $0.75. The original Note, issued on September 30, 2024, has an original principal amount of $2,222,222 and was issued to an accredited and institutional investor under a securities purchase agreement later amended on March 20, 2025.

The company states all other terms of the Note remain in full force and effect. The amendment is filed as Exhibit 10.1.

VSee Health (VSEE) ha modificato la sua nota convertibile senior secured. Il 21 ottobre 2025, la società ha eseguito l'Emendamento n. 1, reimpostando il prezzo di conversione definito della Nota a $0,75. La Nota originale, emessa il 30 settembre 2024, ha un importo principale originario di $2.222.222 ed è stata emessa a un investitore accreditato e istituzionale ai sensi di un accordo di acquisto di titoli successivamente modificato il 20 marzo 2025.

La società afferma che tutti gli altri termini della Nota rimangono in pieno vigore. la modifica è depositata come Allegato 10.1.

VSee Health (VSEE) enmendó su nota convertible senior secured. El 21 de octubre de 2025, la compañía ejecutó la Enmienda n.° 1, restableciendo el «Precio de Conversión» definido de la Nota a $0,75. La Nota original, emitida el 30 de septiembre de 2024, tiene un monto principal original de $2.222.222 y fue emitida a un inversor acreditado e institucional bajo un acuerdo de compra de valores que luego fue enmendado el 20 de marzo de 2025.

La compañía afirma que todos los demás términos de la Nota permanecen en plena vigencia. La enmienda se presenta como el Anexo 10.1.

VSee Health(VSEE)은 자사의 선순위 담보부 전환사채를 수정했다. 2025년 10월 21일 회사는 수정안 No. 1을 실행하여 노트의 정의된 “전환가액”을 $0.75로 재설정했습니다. 원래의 노트는 2024년 9월 30일에 발행되었으며 원금 액면은 달러 2,222,222이고 2025년 3월 20일에 수정된 증권 매매 계약에 따라 공인된 기관투자자에게 발행되었습니다.

회사는 노트의 다른 모든 조항은 여전히 효력을 갖는다고 밝힙니다. 수정안은 부록 10.1로 제출되어 있습니다.

VSee Health (VSEE) a modifié sa note convertible senior secured. Le 21 octobre 2025, la société a exécuté l’Amendement n°1, réinitialisant le « Prix de Conversion » défini de la Note à 0,75 $. La Note originale, émise le 30 septembre 2024, a un montant principal initial de 2 222 222 $ et a été émise à un investisseur accrédité et institutionnel dans le cadre d'un accord d'achat de valeurs mobilières ultérieurement modifié le 20 mars 2025.

La société déclare que toutes les autres conditions de la Note restent en vigueur. L’amendement est déposé comme Annexe 10.1.

VSee Health (VSEE) hat seine senior secured Convertible Note geändert. Am 21. Oktober 2025 hat das Unternehmen Amendment Nr. 1 vorgenommen und den definierten „Conversion Price“ der Note auf 0,75 $ zurückgesetzt. Die ursprüngliche Note, ausgegeben am 30. September 2024, hat einen ursprünglichen Nennbetrag von 2.222.222 $ und wurde an einen akkreditierten und institutionellen Investor gemäß einem Wertpapierkaufvertrag ausgegeben, der am 20. März 2025 später geändert wurde.

Das Unternehmen erklärt, dass alle anderen Bedingungen der Note unverändert in Kraft bleiben. Die Änderung ist als Anhang 10.1 eingereicht.

قامت شركة VSee Health (VSEE) بتعديل صكها القابل للتحويل المضمون كلياً. في 21 أكتوبر 2025، نفذت الشركة التعديل رقم 1، معيدة ضبط السعر المحدد للتحويل في الصك إلى 0.75 دولار. الصك الأصلي، صدر في 30 سبتمبر 2024، له مبلغ رئيسي أصلي قدره 2,222,222 دولار وتم إصداره لمستثمر معتمد ومؤسسي بموجب اتفاق شراء أوراق مالية تم تعديله لاحقاً في 20 مارس 2025.

تؤكد الشركة أن جميع الشروط الأخرى في الصك تظل سارية المفعول. يتم تقديم التعديل كمرفق 10.1.

Positive
  • None.
Negative
  • None.

Insights

Conversion price reset to $0.75; terms otherwise unchanged.

The amendment fixes the Note’s “Conversion Price” at $0.75 for a senior secured convertible instrument originally issued on September 30, 2024 with principal of $2,222,222. By defining a lower per-share conversion level, the document clarifies how debt may convert into equity under the Note.

Potential effects depend on holder conversion decisions and any caps or mechanics contained in the underlying agreements. The company states that, aside from the new conversion price, all other terms remain in effect, and the amendment is included as Exhibit 10.1 for reference.

VSee Health (VSEE) ha modificato la sua nota convertibile senior secured. Il 21 ottobre 2025, la società ha eseguito l'Emendamento n. 1, reimpostando il prezzo di conversione definito della Nota a $0,75. La Nota originale, emessa il 30 settembre 2024, ha un importo principale originario di $2.222.222 ed è stata emessa a un investitore accreditato e istituzionale ai sensi di un accordo di acquisto di titoli successivamente modificato il 20 marzo 2025.

La società afferma che tutti gli altri termini della Nota rimangono in pieno vigore. la modifica è depositata come Allegato 10.1.

VSee Health (VSEE) enmendó su nota convertible senior secured. El 21 de octubre de 2025, la compañía ejecutó la Enmienda n.° 1, restableciendo el «Precio de Conversión» definido de la Nota a $0,75. La Nota original, emitida el 30 de septiembre de 2024, tiene un monto principal original de $2.222.222 y fue emitida a un inversor acreditado e institucional bajo un acuerdo de compra de valores que luego fue enmendado el 20 de marzo de 2025.

La compañía afirma que todos los demás términos de la Nota permanecen en plena vigencia. La enmienda se presenta como el Anexo 10.1.

VSee Health(VSEE)은 자사의 선순위 담보부 전환사채를 수정했다. 2025년 10월 21일 회사는 수정안 No. 1을 실행하여 노트의 정의된 “전환가액”을 $0.75로 재설정했습니다. 원래의 노트는 2024년 9월 30일에 발행되었으며 원금 액면은 달러 2,222,222이고 2025년 3월 20일에 수정된 증권 매매 계약에 따라 공인된 기관투자자에게 발행되었습니다.

회사는 노트의 다른 모든 조항은 여전히 효력을 갖는다고 밝힙니다. 수정안은 부록 10.1로 제출되어 있습니다.

VSee Health (VSEE) a modifié sa note convertible senior secured. Le 21 octobre 2025, la société a exécuté l’Amendement n°1, réinitialisant le « Prix de Conversion » défini de la Note à 0,75 $. La Note originale, émise le 30 septembre 2024, a un montant principal initial de 2 222 222 $ et a été émise à un investisseur accrédité et institutionnel dans le cadre d'un accord d'achat de valeurs mobilières ultérieurement modifié le 20 mars 2025.

La société déclare que toutes les autres conditions de la Note restent en vigueur. L’amendement est déposé comme Annexe 10.1.

VSee Health (VSEE) hat seine senior secured Convertible Note geändert. Am 21. Oktober 2025 hat das Unternehmen Amendment Nr. 1 vorgenommen und den definierten „Conversion Price“ der Note auf 0,75 $ zurückgesetzt. Die ursprüngliche Note, ausgegeben am 30. September 2024, hat einen ursprünglichen Nennbetrag von 2.222.222 $ und wurde an einen akkreditierten und institutionellen Investor gemäß einem Wertpapierkaufvertrag ausgegeben, der am 20. März 2025 später geändert wurde.

Das Unternehmen erklärt, dass alle anderen Bedingungen der Note unverändert in Kraft bleiben. Die Änderung ist als Anhang 10.1 eingereicht.

false 0001864531 0001864531 2025-10-21 2025-10-21 0001864531 vsee:CommonStock0.0001ParValuePerShareMember 2025-10-21 2025-10-21 0001864531 vsee:WarrantsWhichEntitlesHolderToPurchaseOne1ShareOfCommonStockAtPriceOf11.50PerWholeShareMember 2025-10-21 2025-10-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

  

 

 

FORM 8-K

  

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 21, 2025

 

VSEE HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41015   86-2970927
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

980 N Federal Hwy #304
Boca Raton, Florida
  33432
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (561) 672-7068

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Title of each class   Trading Symbol   Name of each exchange on
which registered
Common Stock, $0.0001 par value per share   VSEE   The Nasdaq Stock Market LLC
Warrants, which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share   VSEEW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement

 

On October 21, 2025, VSee Health, Inc. (the “Company”), entered into an Amendment No. 1 (the “Amendment”) to the senior secured convertible promissory note, issued on September 30, 2024 (the “Note”) in the original principal amount of $2,222,222 (the “Note”), with the accredited and institutional investor (the “Holder”). The Note was previously issued by the Company to the Holder pursuant to the securities purchase agreement, dated September 30, 2024, as amended on March 20, 2025, by and among the Company and the Holder.

 

The Amendment revises the definition of “Conversion Price” as set forth in the Note to be equal to $0.75.

  

Except as specifically set forth in the Amendment, all other terms, covenants, and conditions of the Note remain in full force and effect. The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference herein.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits:

 

Exhibit   Description
     
10.1   Amendment No. 1 to the Senior Secured Convertible Promissory Note, dated October 21, 2025, by and between VSee Health, Inc. and the investor therein
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: October 21, 2025 VSEE HEALTH, INC.
     
  By: /s/ Imoigele Aisiku
  Name:  Imoigele Aisiku
  Title: Co-Chief Executive Officer

 

2

 

 

 

FAQ

What did VSee Health (VSEE) change in its convertible note?

The company reset the Note’s defined “Conversion Price” to $0.75.

What is the original principal amount of VSEE’s convertible note?

The original principal amount is $2,222,222.

When was the amendment to the Note executed?

The amendment was executed on October 21, 2025.

When was the original Note issued?

The original Note was issued on September 30, 2024.

Did any other terms of the Note change?

No. The company states all other terms remain in full force and effect.

Where can I find the full amendment document?

It is filed as Exhibit 10.1 to the report.

What are VSEE’s listed securities and symbols?

Common Stock: VSEE; Warrants (exercise price $11.50 per whole share): VSEEW.
VSee Health, Inc.

NASDAQ:VSEE

VSEE Rankings

VSEE Latest News

VSEE Latest SEC Filings

VSEE Stock Data

11.41M
7.87M
56.34%
4.51%
0.55%
Health Information Services
Services-health Services
Link
United States
BOCA RATON